Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036341
Disease: Schizophrenia
Schizophrenia 		0.110 GeneticVariation disease GWASCAT Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect. 30285260 2019
CUI: C0036341
Disease: Schizophrenia
Schizophrenia 		0.110 GeneticVariation disease GWASCAT Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association Study. 31268507 2019
CUI: C0036341
Disease: Schizophrenia
Schizophrenia 		0.110 GeneticVariation disease GWASCAT Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia. 28991256 2017
CUI: C0036341
Disease: Schizophrenia
Schizophrenia 		0.110 GeneticVariation disease BEFREE In addition, we identified differentially methylated CpG sites in LRP2BP (P-value=5.37 × 10<sup>-8</sup>) to be associated with intellectual disability (F70-79), in TOP1 (P-value=1.86 × 10<sup>-7</sup>) with behavioral disorders (F90-98), in NOSIP (P-value=5.12 × 10<sup>-8</sup>) with disorders of psychological development (F80-89) and in SEMA4B (P-value=4.02 × 10<sup>-7</sup>) with schizophrenia spectrum disorders (F20-29). 28850114 2017
CUI: C0036341
Disease: Schizophrenia
Schizophrenia 		0.110 GeneticVariation disease GWASCAT Genome-wide association study of schizophrenia in Ashkenazi Jews. 26198764 2015
CUI: C0036341
Disease: Schizophrenia
Schizophrenia 		0.110 GeneticVariation disease GWASCAT Biological insights from 108 schizophrenia-associated genetic loci. 25056061 2014
CUI: C0014772
Disease: Red Blood Cell Count measurement
Red Blood Cell Count measurement 		0.100 GeneticVariation phenotype GWASCAT The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. 27863252 2016
CUI: C0018935
Disease: Hematocrit procedure
Hematocrit procedure 		0.100 GeneticVariation phenotype GWASCAT The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. 27863252 2016
CUI: C0235833
Disease: Congenital diaphragmatic hernia
Congenital diaphragmatic hernia 		0.010 AlteredExpression disease BEFREE Expression of Nitric Oxide Synthase Interacting Protein (NOSIP) is Decreased in the Pulmonary Vasculature of Nitrofen-Induced Congenital Diaphragmatic Hernia. 30536263 2019
CUI: C0004936
Disease: Mental disorders
Mental disorders 		0.010 Biomarker group BEFREE The nitric oxide synthase interacting protein (Nosip) has been associated with diverse human diseases including psychological disorders. 30055071 2018
CUI: C0025958
Disease: Microcephaly
Microcephaly 		0.010 AlteredExpression disease BEFREE Nosip knockout mice show craniofacial defects and the down-regulation of Nosip in the mouse and Xenopus leads to microcephaly. 30055071 2018
CUI: C0004930
Disease: Behavior Disorders
Behavior Disorders 		0.010 GeneticVariation group BEFREE In addition, we identified differentially methylated CpG sites in LRP2BP (P-value=5.37 × 10<sup>-8</sup>) to be associated with intellectual disability (F70-79), in TOP1 (P-value=1.86 × 10<sup>-7</sup>) with behavioral disorders (F90-98), in NOSIP (P-value=5.12 × 10<sup>-8</sup>) with disorders of psychological development (F80-89) and in SEMA4B (P-value=4.02 × 10<sup>-7</sup>) with schizophrenia spectrum disorders (F20-29). 28850114 2017
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior 		0.010 GeneticVariation phenotype BEFREE In addition, we identified differentially methylated CpG sites in LRP2BP (P-value=5.37 × 10<sup>-8</sup>) to be associated with intellectual disability (F70-79), in TOP1 (P-value=1.86 × 10<sup>-7</sup>) with behavioral disorders (F90-98), in NOSIP (P-value=5.12 × 10<sup>-8</sup>) with disorders of psychological development (F80-89) and in SEMA4B (P-value=4.02 × 10<sup>-7</sup>) with schizophrenia spectrum disorders (F20-29). 28850114 2017
CUI: C0478658
Disease: Disorder of psychological development
Disorder of psychological development 		0.010 GeneticVariation group BEFREE In addition, we identified differentially methylated CpG sites in LRP2BP (P-value=5.37 × 10<sup>-8</sup>) to be associated with intellectual disability (F70-79), in TOP1 (P-value=1.86 × 10<sup>-7</sup>) with behavioral disorders (F90-98), in NOSIP (P-value=5.12 × 10<sup>-8</sup>) with disorders of psychological development (F80-89) and in SEMA4B (P-value=4.02 × 10<sup>-7</sup>) with schizophrenia spectrum disorders (F20-29). 28850114 2017
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability 		0.010 GeneticVariation group BEFREE In addition, we identified differentially methylated CpG sites in LRP2BP (P-value=5.37 × 10<sup>-8</sup>) to be associated with intellectual disability (F70-79), in TOP1 (P-value=1.86 × 10<sup>-7</sup>) with behavioral disorders (F90-98), in NOSIP (P-value=5.12 × 10<sup>-8</sup>) with disorders of psychological development (F80-89) and in SEMA4B (P-value=4.02 × 10<sup>-7</sup>) with schizophrenia spectrum disorders (F20-29). 28850114 2017
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases 		0.010 Biomarker group BEFREE Validation of 4 PVAN-specific genes (RPS15, complement factor D, lactotransferrin, and nitric oxide synthase interacting protein) by quantitative polymerase chain reaction and confirmation by immunohistochemistry of 2 PVAN-specific proteins with antiviral function (lactotransferrin and IFN-inducible transmembrane 1) was done. 27140517 2016
CUI: C0206663
Disease: Neuroectodermal Tumor, Primitive
Neuroectodermal Tumor, Primitive 		0.010 AlteredExpression disease BEFREE NOSIP produces a significant reduction in nNOS activity in a neuroepithelioma cell line stably expressing nNOS. 15548660 2004
CUI: C4048305
Disease: Neuroepithelioma
Neuroepithelioma 		0.010 AlteredExpression disease BEFREE NOSIP produces a significant reduction in nNOS activity in a neuroepithelioma cell line stably expressing nNOS. 15548660 2004